CYP94B3 activity against jasmonic acid amino acid conjugates and the elucidation of 12-O-β-glucopyranosyl-jasmonoyl-l-isoleucine as an additional metabolite

CYP94B3 activity was re-examined to prove that JA-Val and JA-Phe were received hydroxylation at C12 position. These findings led the conclusion that this path way is important to deactivate active form of jasmonate.